This briefing summarises NICEs recommendations for local authorities and partner organisations on preventing people becoming overweight and obese and helping them to manage their weight. It is particularly relevant to health and wellbeing boards.Adults with a body mass index or BMI weight in kg/height in m2 of over 30 are classified as obese and those with a BMI of 25–29.9 are classified as overweight. See Public Health Englands Measuring and interpreting BMI in children to determine when children are overweight or obese.
NICE will develop quality standards to hold the NHS to account for its public health activity for the first time, with the first to look at tobacco, harmful use of alcohol and obesity, the Government has announced.
This is an update to an information consultancy originally produced in August 2011. It is recommended you read both. To view August 2011 consultancy – please click here
An evidence summary produced by Bolton’s Health Matters. Please click on the link to view. This is an original piece of work. Please contact the library if you wish to re-use in any format.
This piece of work was produced by
An evidence summary produced by NHS Bolton Library. Please click on the link to view. This is an original piece of work. Please contact the library if you wish to re-use in any format.
Produced by Amy Faye Finnegan and Michael Cook
In its response to the Health Select Committee’s report on the future role of the National Institute for Health and Clinical Excellence (NICE), the government has confirmed NICE will:
- have a crucial role in the future value-based pricing arrangements for branded medicines.
- build on its current drug evaluation processes by giving it broader scope to assess a medicine’s benefits and costs. The aim is to make sure that the price the NHS pays for new medicines is more closely linked to their value to NHS patients and society.
Too few women are on CCG boards – meaning they don’t properly represent the workforce or the local population
NICE will take responsibility for assessing the full value of medicines when new pricing arrangements are introduced in 2014 the Government announced today.